While rare, its possible to experience pancreatitis (inflammation of the pancreas), kidney problems (like kidney stones), acute gallbladder disease, and an increased risk of thyroid cancer
doi: 10.1111/j.1600-079X.1996.tb00256.x 51 RothJJGernWARothECRalphCLJacobsonE
When choosing between Mochi and iV.im, patients often overlook a critical layer: genetic predispositions in peptide pathways that may influence treatment response and side-effect tolerance

KEY TAKEAWAYS Weight and metabolic health are not the same thing - you can be metabolically unhealthy at any size Normal weight people with metabolic dysfunction are often overlooked and undertreated by healthcare providers Key screening tests include fasting glucose, insulin, HbA1c, triglycerides, HDL cholesterol, blood pressure, and inflammatory markers like HSCRP Metabolic dysfunction can start in your 20s and take decades to develop into serious disease Both normal weight and higher weight patients face bias - normal weight people aren't screened enough, while higher weight people have everything blamed on their weight Early screening and treatment can prevent catastrophic health outcomes later in life The liver plays a crucial role in metabolism and can become insulin resistant regardless of body weight NOTABLE QUOTE "You cannot tell anything about someone's health from their outside, what they look like or what, even what they're doing necessarily, but definitely not their body size

doi: 10.1161/CIRCRESAHA.108.190918 37 WuY